[1]朱悦琦,程英升,李明华.经皮经肝穿刺门静脉置管术在良性肝脏及胰腺疾病中的临床应用[J].介入放射学杂志,2007,(02):135.
 ZHU Yue-qi,CHENG Ying-sheng,LI Ming-hua.Percutaneous transhepatic portal vein puncture with indwelling catheter for benign hepatic and pancreatic diseases:clinical application[J].journal interventional radiology,2007,(02):135.
点击复制

经皮经肝穿刺门静脉置管术在良性肝脏及胰腺疾病中的临床应用()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2007年02期
页码:
135
栏目:
综述
出版日期:
2007-02-15

文章信息/Info

Title:
Percutaneous transhepatic portal vein puncture with indwelling catheter for benign hepatic and pancreatic diseases:clinical application
作者:
朱悦琦程英升李明华
200233上海交通大学附属第六人民医院放射科
Author(s):
ZHU Yue-qiCHENG Ying-shengLI Ming-hua.
Department of Radiology,Sixth People's Hospital Affiliated to Shanghai Jiaotong University.Shanghai200233,China
关键词:
门脉穿刺门脉置管β细胞栓塞溶栓
分类号:
R575.2
文献标志码:
A
摘要:
经皮经肝穿刺门静脉置管术目前已广泛应用于临床介入治疗,尤其是肝脏、胰腺恶性肿瘤的化疗中,而在肝脏和胰腺的良性病变中应用尚不多。这一技术除了具有创伤小等特点,还能明显的提高门脉血药浓度,达到静脉给药血药浓度的100~400倍,在肝脏和胰腺的良性疾病如肝炎、肝硬化、糖尿病中都有着广泛的应用前景。随着穿刺技术,材料学及置管方法的改进和发展,经皮经肝穿刺门静脉置管术必将在肝脏和胰腺良性疾病的介入治疗中扮演越来越重要的角色。

参考文献/References:

[1]梁宗志,褚梅群,李蓉.经门脉灌注给药治疗乙肝、肝硬变的临床研究(附39例报告)[J].中国综合临床,2001,17:517-518.
[2]刘利民,徐智章,吴晓凤.超声引导经穿刺针内腔门脉留置导管化疗[J].中华超声影像学杂志,1998,7:242-243.
[3]李彦豪,陈勇.经皮门脉导管药盒系统植入术[J].中华放射学杂志,1997,31:176-179.
[4]陈勇,李彦豪.门脉穿刺插管术的临床应用及进展[J].国外医学临床放射学分册,1997,6:344-346.
[5]吕宜光,杨在梅,吕明贵.超声引导下门静脉穿刺长期留置导管治疗肝癌18例[J].中国冶金工业医学杂志,2000,17:157-158.
[6]Gaber AO,Fraga D,Fisher J,et al.Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation[J].Transplantation,2004,77:309-311.
[7]Distefano G,Rodond A,Cilauro S,et al.Fibrinolytic treatment of portal vein thrombosis after umbilical catheterization using systemic urokinase[J].Pediatrics International,2000,42:82-84.
[8]Fukuda T,Hirota S,Sugimoto K.“Downgrading”of gastric varices with multiple collateral veins in balloon-occluded retrograde transvenous obliteration[J].JVIR,2005,16:1379-1383.
[9]胡元明,谢宗贵,单鸿.经皮经肝食管胃底静脉曲张栓塞术的临床应用[J].中华放射学杂志,2005,39:736-738.
[10]Seymour K,Charnley RM,Rose JDG,et al.Preoperative portalvein embolisation for primary and metastatic liver tumours:volume effects,efficacy,complications and short-term outcome[J].HPB,2002,4:21-28.
[11]Brown KT,Brody LA,Decorato DR,et al.Portal vein emboli-zation with use of polyvinyl alcohol particles[J].JVIR,2001,12:882-886.
[12]Mezawa S,Homma H,Akiyama T,et al.Selective embolization of the splenic vein in patients with hepatic encephalopathy and splenorenal shunt[J].JVIR,2004,15:1475-1481.
[13]冯子坛,姚欣,李淑敏,等.经门静脉给药泵溶栓治愈门静脉血栓的体会[J].华北国防医药,2004,16,427-428.
[14]Kim HS,Patra A,Khan J,et al.Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis[J].JVIR,2005,16:1685-1691.
[15]Saravanan R,Nayar M,Gilmore IT,et al.Transjugular intrahe-patic portosystemic stent shunt:11years' experience at a regional referral centre[J].Eur J Gastroenterol Hepatol,2005,17:1165-1171.
[16]de Vries GJ,Ryan BM,de Bie`vre M,et al.Cirrhosis related chylous ascites successfully treated with TIPS[J].Eur J Gastroenterol Hepatol,2005,17:463-466.
[17]Vivas I,Bilbao JI,Martínez-Cuesta A.Percutaneous extrahe-patic portacaval shunt with covered prostheses:feasibility study[J].JIVR,2003,14:1543-1552.
[18]谢宗贵,胡元明,王小珍.经门静脉药物灌注治疗肝硬化[J].介入放射学杂志,2005,14:549-551.
[19]Robertson RP,Kendall DM.Islet transplantation2003:ques-tions about its future[J].Diabetes Endocr Pancr.2003,128-132.
[20]Maleux G,Gillard P,Keymeulen B,et al.Feasibility,safety,and efficacy of percutaneous transhepatic injection of cell grafts[J].JVIR,2005,16:1693-1697.
[21]Philosophe B,Farney AC,Schweitzer EJ,et al.Superiority of portal venous drainage over systemic venous drainage in pancreast transplantation:a retrospective study[J].Ann Surg,2001,234:689-696.

备注/Memo

备注/Memo:
收稿日期:2005-11-28
更新日期/Last Update: 2007-02-15